Bifidobacterium SPP: The Promising Trojan Horse in the Era of Precision Oncology

References

• Zhuang C , GuanX, MaH, CongH, ZhangW, MiaoZ. Small molecule-drug conjugates: a novel strategy for cancer-targeted treatment. Eur. J. Med. Chem.163, 883–895 (2019).
   PubMed Web of Science ®Google Scholar
• Senapati S , MahantaAK, KumarS, MaitiP. Controlled drug delivery vehicles for cancer treatment and their performance. Signal. Transduct. Target. Ther.3(1), 7 (2018).
   PubMed Web of Science ®Google Scholar
• Szakacs G , PatersonJK, LudwigJA, Booth-GentheC, GottesmanMM. Targeting multidrug resistance in cancer. Nat. Rev. Drug Discov.5(3), 219–234 (2006).
   PubMed Web of Science ®Google Scholar
• Casi G , NeriD. Antibody–drug conjugates and small molecule–drug conjugates: opportunities and challenges for the development of selective anticancer cytotoxic agents. J. Med. Chem.58(22), 8751–8761 (2015).
   PubMed Web of Science ®Google Scholar
• Chari RV , MillerML, WiddisonWC. Antibody–drug conjugates: an emerging concept in cancer therapy. Angew. Chem. Int. Ed. Engl.53(15), 3796–3827 (2014).
   PubMed Web of Science ®Google Scholar
• Srinivasarao M , GallifordCV, LowPS. Principles in the design of ligand-targeted cancer therapeutics and imaging agents. Nat. Rev. Drug Discov.14(3), 203–219 (2015).
   PubMed Web of Science ®Google Scholar
• Lu ZR , QiaoP. Drug delivery in cancer therapy, quo vadis?Mol. Pharm.15(9), 3603–3616 (2018).
   PubMedGoogle Scholar
• Tzakos AG , BriasoulisE, ThalhammerT, JagerW, ApostolopoulosV. Novel oncology therapeutics: targeted drug delivery for cancer. J. Drug Deliv.2013, 918304 (2013).
   PubMedGoogle Scholar
• Yun YH , LeeBK, ParkK. Controlled drug delivery: historical perspective for the next generation. J. Control. Rel.219, 2–7 (2015).
   PubMed Web of Science ®Google Scholar
• Allen TM , CullisPR. Liposomal drug delivery systems: from concept to clinical applications. Adv. Drug Deliv. Rev.65(1), 36–48 (2013).
   PubMed Web of Science ®Google Scholar
• Ljubimova JY , SunT, MashoufLet al. Covalent nano delivery systems for selective imaging and treatment of brain tumors. Adv. Drug Deliv. Rev.113, 177–200 (2017).
   PubMed Web of Science ®Google Scholar
• Zhou Y , KopecekJ. Biological rationale for the design of polymeric anti-cancer nanomedicines. J. Drug Target.21(1), 1–26 (2013).
   PubMed Web of Science ®Google Scholar
• Dong Y , EltoukhyAA, AlabiCAet al. Lipid-like nanomaterials for simultaneous gene expression and silencing in vivo. Adv. Healthc. Mater.3(9), 1392–1397 (2014).
   PubMed Web of Science ®Google Scholar
• Kumar S , SinghS, SenapatiS, SinghAP, RayB, MaitiP. Controlled drug release through regulated biodegradation of poly(lactic acid) using inorganic salts. Int. J. Biol. Macromol.104(Pt A), 487–497 (2017).
   PubMedGoogle Scholar
• Li Y , MacielD, RodriguesJ, ShiX, TomasH. Biodegradable polymer nanogels for drug/nucleic acid delivery. Chem. Rev.115(16), 8564–8608 (2015).
   PubMed Web of Science ®Google Scholar
• Mo R , JiangT, GuZ. Recent progress in multidrug delivery to cancer cells by liposomes. Nanomedicine9(8), 1117–1120 (2014).
   PubMed Web of Science ®Google Scholar
• Shih H , LinCC. Photoclick hydrogels prepared from functionalized cyclodextrin and poly(ethylene glycol) for drug delivery and in situ cell encapsulation. Biomacromolecules16(7), 1915–1923 (2015).
   PubMed Web of Science ®Google Scholar
• Shim MS , KwonYJ. Stimuli-responsive polymers and nanomaterials for gene delivery and imaging applications. Adv. Drug Deliv. Rev.64(11), 1046–1059 (2012).
   PubMed Web of Science ®Google Scholar
• Su J , ChenF, CrynsVL, MessersmithPB. Catechol polymers for pH-responsive, targeted drug delivery to cancer cells. J. Am. Chem. Soc.133(31), 11850–11853 (2011).
   PubMed Web of Science ®Google Scholar
• Sun W , GuZ. Engineering DNA scaffolds for delivery of anticancer therapeutics. Biomater. Sci.3(7), 1018–1024 (2015).
   PubMed Web of Science ®Google Scholar
• Ahn S , SeoE, KimK, LeeSJ. Controlled cellular uptake and drug efficacy of nanotherapeutics. Sci. Rep.3, 1997 (2013).
   PubMed Web of Science ®Google Scholar
• Murty S , GillilandT, QiaoPet al. Nanoparticles functionalized with collagenase exhibit improved tumor accumulation in a murine xenograft model. Part. Part. Syst. Charact.31(12), 1307–1312 (2014).
   PubMed Web of Science ®Google Scholar
• Han Z , LuZR. Targeting fibronectin for cancer imaging and therapy. J. Mater. Chem. B5(4), 639–654 (2017).
   PubMed Web of Science ®Google Scholar
• Zhou Z , LuZR. Molecular imaging of the tumor microenvironment. Adv. Drug Deliv. Rev.113, 24–48 (2017).
   PubMed Web of Science ®Google Scholar
• Patyar S , JoshiR, ByravDS, PrakashA, MedhiB, DasBK. Bacteria in cancer therapy: a novel experimental strategy. J. Biomed. Sci.17(1), 21 (2010).
   PubMedGoogle Scholar
• Robbins PD , GhivizzaniSC. Viral vectors for gene therapy. Pharmacol. Ther.80(1), 35–47 (1998).
   PubMed Web of Science ®Google Scholar
• Hall DM , BuettnerGR, MatthesRD. A Commotion in the Blood. Henry Holt and Company, Inc., NY, USA (1997).
   Google Scholar
• Coley WB II . Contribution to the knowledge of sarcoma. Ann. Surg.14(3), 199–220 (1891).
   PubMedGoogle Scholar
• Coley WB . Late results of the treatment of inoperable sarcoma by the mixed toxins of erysipelas and Bacillus prodigiosus. Am. J. Med. Sci.131, 371 (1906).
   Google Scholar
• Fehleisen F . Die Aetiologie Des Erysipels.Verlag von Theodor Fischer’s medicinischer Buchhandlung, Berlin, Germany (1883).
   Google Scholar
• Nauts HC . The Beneficial Effects of Bacterial Infections on Host Resistance to Cancer End Results in 449 Cases: A Study and Abstracts of Reports in the World Medical Literature (1775-1980) and Personal Communications.Cancer Research Institute, NY, USA (1980).
   Google Scholar
• Nauts HC , FowlerGA, BogatkoFH. A review of the influence of bacterial infection and of bacterial products (Coley’s toxins) on malignant tumors in man; a critical analysis of 30 inoperable cases treated by Coley’s mixed toxins, in which diagnosis was confirmed by microscopic examination selected for special study. Acta Med. Scand. Suppl.276, 1–103 (1953).
   PubMedGoogle Scholar
• Pawelek JM , LowKB, BermudesD. Bacteria as tumour-targeting vectors. Lancet Oncol.4(9), 548–556 (2003).
   PubMed Web of Science ®Google Scholar
• Chapter 3 – Supragingival microbes. In: Atlas of Oral Microbiology. ZhouX, LiY ( Eds). Academic Press, Oxford, UK, 41–65 (2015).
   Google Scholar
• Tissier H . Recherches sur la flore intestinale des nourrissons:(état normal et pathologique). G. Carre et C. Naud, Paris, France (1900).
   Google Scholar
• Ventura M , TurroniF, Van SinderenD. Chapter 4 - Bifidobacteria of the human gut: our special friends. In: Diet-Microbe Interactions in the Gut. TuohyK, DelRio D ( Eds). Academic Press, CA, USA, 41–51 (2015).
   Google Scholar
• Lee JH , O’SullivanDJ. Genomic insights into bifidobacteria. MMBR74(3), 378–416 (2010).
   Google Scholar
• NCBI . The National Center for Biotechnology Information Taxonomy browser (2019). www.ncbi.nlm.nih.gov
   Google Scholar
• O’Callaghan A , Van SinderenD. Bifidobacteria and their role as members of the human gut microbiota. Front. Microbiol.7, 925 (2016).
   PubMed Web of Science ®Google Scholar
• Esaiassen E , HjerdeE, CavanaghJP, SimonsenGS, KlingenbergC. Bifidobacterium bacteremia: clinical characteristics and a genomic approach to assess pathogenicity. J. Clin. Microbiol.55(7), 2234–2248 (2017).
   PubMed Web of Science ®Google Scholar
• Mccartney AL . Bifidobacteria in foods. In: Encyclopedia of Food Sciences and Nutrition (2nd Edition). CaballeroB ( Ed.). Academic Press, Oxford, UK, 463–470 (2003).
   Google Scholar
• Rašić JL . Microflora of the intestine | probiotics. In: Encyclopedia of Food Sciences and Nutrition (2nd Edition). CaballeroB ( Ed.). Academic Press, Oxford, UK, 3911–3916 (2003).
   Google Scholar
• Ouwehand AC , SalminenS, IsolauriE. Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek.82(1-4), 279–289 (2002).
   PubMed Web of Science ®Google Scholar
• Salminen S , Von WrightA, MorelliLet al. Demonstration of safety of probiotics – a review. Int. J. Food Microbiol.44(1-2), 93–106 (1998).
   PubMed Web of Science ®Google Scholar
• Shah N . Yogurt | the product and its manufacture. In: Encyclopedia of Food Sciences and Nutrition (2nd Edition). CaballeroB ( Ed.). Academic Press, Oxford, UK, 6252–6259 (2003).
   Google Scholar
• Abratt VR , ReidSJ. Chapter 3 - Oxalate-degrading bacteria of the human gut as probiotics in the management of kidney stone disease. In: Advances in Applied Microbiology. LaskinAI, SariaslaniS, GaddGM ( Eds). Academic Press, Oxford, UK, 63–87 (2010).
   Google Scholar
• Bourne KA , BeebeJL, LueYA, EllnerPD. Bacteremia due to Bifidobacterium, Eubacterium or Lactobacillus; twenty-one cases and review of the literature. Yale J. Biol. Med.51(5), 505–512 (1978).
   PubMed Web of Science ®Google Scholar
• Weber E , ReynaudQ, SuyFet al. Bifidobacterium species bacteremia: risk factors in adults and infants. Clin. Infect. Dis.61(3), 482–484 (2015).
   PubMed Web of Science ®Google Scholar
• Quigley EMM . Chapter 12 - Bifidobacteria as probiotic organisms: an introduction. In: The Microbiota in Gastrointestinal Pathophysiology. FlochMH, RingelY, AllanWalker W ( Eds). Academic Press, Boston, USA, 125–126 (2017).
   Google Scholar
• Bae E-A , KimD-H, HanM. Anti-Helicobacter pylori activity of Bifidobacterium spp. J. Microbiol. Biotechnol.10(4), 532–534 (2000).
   Web of Science ®Google Scholar
• Corrêa NB , PéretFilho LA, PennaFJ, LimaFMS, NicoliJR. A randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophilus for prevention of antibiotic-associated diarrhea in infants. J. Clin. Gastroenterol.39(5), 385–389 (2005).
   PubMed Web of Science ®Google Scholar
• Ambalam P , RamanM, PuramaRK, DobleM. Probiotics, prebiotics and colorectal cancer prevention. Best Pract. Res. Clin. Gastroenterol.30(1), 119–131 (2016).
   PubMed Web of Science ®Google Scholar
• Hidalgo-Cantabrana C , DelgadoS, RuizL, Ruas-MadiedoP, SanchezB, MargollesA. Bifidobacteria and their health-promoting effects. Microbiol. Spectr.5(3), (2017).
   PubMed Web of Science ®Google Scholar
• Wilkins T , SequoiaJ. Probiotics for gastrointestinal conditions: a summary of the evidence. Am. Fam. Physician96(3), 170–178 (2017).
   PubMed Web of Science ®Google Scholar
• Kleessen B , SykuraB, ZunftHJ, BlautM. Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons. Am. J. Clin. Nutrition65(5), 1397–1402 (1997).
   PubMed Web of Science ®Google Scholar
• Kumemura M , HashimotoF, FujiiCet al. Effects of administration of 4G-β-D-galactosylsucrose on fecal microflora, putrefactive products, short-chain fatty acids, weight, moisture and pH, and subjective sensation of defecation in the elderly with constipation. J. Clin. Biochem. Nutrition13(3), 199–210 (1992).
   Web of Science ®Google Scholar
• Tanaka R , TakayamaH, MorotomiMet al. Effects of administration of TOS and Bifidobacterium breve 4006 on the human fecal flora. Bifidobacteria Microflora2(1), 17–24 (1983).
   Google Scholar
• Gionchetti P , RizzelloF, VenturiAet al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology119(2), 305–309 (2000).
   PubMed Web of Science ®Google Scholar
• Patole SK , RaoSC, KeilAD, NathanEA, DohertyDA, SimmerKN. Benefits of Bifidobacterium breve M-16V supplementation in preterm neonates – a retrospective cohort study. PLoS ONE11(3), e0150775 (2016).
   PubMed Web of Science ®Google Scholar
• Venturi A , GionchettiP, RizzelloFet al. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment. Pharmacol. Ther.13(8), 1103–1108 (1999).
   PubMed Web of Science ®Google Scholar
• Xu J , MaR, ChenLF, ZhaoLJ, ChenK, ZhangRB. Effects of probiotic therapy on hepatic encephalopathy in patients with liver cirrhosis: an updated meta-analysis of six randomized controlled trials. Hepatobiliary Pancreat. Dis. Int.13(4), 354–360 (2014).
   PubMed Web of Science ®Google Scholar
• Cristofori F , IndrioF, MinielloVL, DeAngelis M, FrancavillaR. Probiotics in celiac disease. Nutrients10(12), (2018).
   Web of Science ®Google Scholar
• Luoto R , LaitinenK, NermesM, IsolauriE. Impact of maternal probiotic-supplemented dietary counselling on pregnancy outcome and prenatal and postnatal growth: a double-blind, placebo-controlled study. Br. J. Nutr.103(12), 1792–1799 (2010).
   PubMed Web of Science ®Google Scholar
• Yao K , ZengL, HeQ, WangW, LeiJ, ZouX. Effect of probiotics on glucose and lipid metabolism in type 2 diabetes mellitus: a meta-analysis of 12 randomized controlled trials. Med. Sci. Monit.23, 3044–3053 (2017).
   PubMed Web of Science ®Google Scholar
• Rondanelli M , FalivaMA, PernaS, GiacosaA, PeroniG, CastellazziAM. Using probiotics in clinical practice: where are we now? A review of existing meta-analyses. Gut Microbes8(6), 521–543 (2017).
   PubMed Web of Science ®Google Scholar
• Shimizu M , HashiguchiM, ShigaT, TamuraHO, MochizukiM. Meta-analysis: effects of probiotic supplementation on lipid profiles in normal to mildly hypercholesterolemic individuals. PLoS ONE10(10), e0139795 (2015).
   PubMed Web of Science ®Google Scholar
• Borgeraas H , JohnsonLK, SkattebuJ, HertelJK, HjelmesaethJ. Effects of probiotics on body weight, body mass index, fat mass and fat percentage in subjects with overweight or obesity: a systematic review and meta-analysis of randomized controlled trials. Obes. Rev.19(2), 219–232 (2018).
   PubMed Web of Science ®Google Scholar
• Messaoudi M , ViolleN, BissonJF, DesorD, JavelotH, RougeotC. Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes2(4), 256–261 (2011).
   PubMed Web of Science ®Google Scholar
• Ng QX , PetersC, HoCYX, LimDY, YeoWS. A meta-analysis of the use of probiotics to alleviate depressive symptoms. J. Affect. Disord.228, 13–19 (2018).
   PubMed Web of Science ®Google Scholar
• Okubo R , KogaM, KatsumataNet al. Effect of bifidobacterium breve A-1 on anxiety and depressive symptoms in schizophrenia: a proof-of-concept study. J. Affect. Disord.245, 377–385 (2019).
   PubMed Web of Science ®Google Scholar
• Dermyshi E , WangY, YanCet al. The “Golden Age” of probiotics: a systematic review and meta-analysis of randomized and observational studies in preterm infants. Neonatology112(1), 9–23 (2017).
   PubMed Web of Science ®Google Scholar
• Liboredo JC , AnastacioLR, PeluzioMdo Cet al. Effect of probiotics on the development of dimethylhydrazine-induced preneoplastic lesions in the mice colon. Acta Cir. Bras.28(5), 367–372 (2013).
   PubMed Web of Science ®Google Scholar
• Wei C , XunAY, WeiXXet al. Bifidobacteria expressing tumstatin protein for antitumor therapy in tumor-bearing mice. Technol. Cancer Res. Treat.15(3), 498–508 (2016).
   PubMed Web of Science ®Google Scholar
• Kim KA , JungIH, ParkSH, AhnYT, HuhCS, KimDH. Comparative analysis of the gut microbiota in people with different levels of ginsenoside Rb1 degradation to compound K. PLoS ONE8(4), e62409 (2013).
   PubMed Web of Science ®Google Scholar
• Lai LR , HsiehSC, HuangHY, ChouCC. Effect of lactic fermentation on the total phenolic, saponin and phytic acid contents as well as anti-colon cancer cell proliferation activity of soymilk. J. Biosci. Bioeng.115(5), 552–556 (2013).
   PubMed Web of Science ®Google Scholar
• Schroeder BO , BirchenoughGMH, StahlmanMet al. Bifidobacteria or fiber protects against diet-induced microbiota-mediated colonic mucus deterioration. Cell Host Microbe23(1), 27–40 (2018). e27
   PubMed Web of Science ®Google Scholar
• Yazawa K , FujimoriM, AmanoJ, KanoY, TaniguchiS. Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors. Cancer Gene Ther.7(2), 269–274 (2000).
   PubMed Web of Science ®Google Scholar
• Pool-Zobel BL , NeudeckerC, DomizlaffIet al. Lactobacillus- and bifidobacterium-mediated antigenotoxicity in the colon of rats. Nutr. Cancer26(3), 365–380 (1996).
   PubMed Web of Science ®Google Scholar
• Tavan E , CayuelaC, AntoineJM, TrugnanG, ChaugierC, CassandP. Effects of dairy products on heterocyclic aromatic amine-induced rat colon carcinogenesis. Carcinogenesis23(3), 477–483 (2002).
   PubMed Web of Science ®Google Scholar
• Sekine K , ToidaT, SaitoM, KuboyamaM, KawashimaT, HashimotoY. A new morphologically characterized cell wall preparation (whole peptidoglycan) from Bifidobacterium infantis with a higher efficacy on the regression of an established tumor in mice. Cancer Res.45(3), 1300–1307 (1985).
   PubMed Web of Science ®Google Scholar
• Yasui H , OhwakiM. Enhancement of immune response in Peyer’s patch cells cultured with Bifidobacterium breve. J. Dairy Sci.74(4), 1187–1195 (1991).
   PubMed Web of Science ®Google Scholar
• Sivan A , CorralesL, HubertNet al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy. Science350(6264), 1084–1089 (2015).
   PubMed Web of Science ®Google Scholar
• Kimura NT , TaniguchiS, AokiK, BabaT. Selective localization and growth of Bifidobacterium bifidum in mouse tumors following intravenous administration. Cancer Res.40(6), 2061–2068 (1980).
   PubMed Web of Science ®Google Scholar
• Muz B , DeLa Puente P, AzabF, AzabAK. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia3, 83–92 (2015).
   PubMed Web of Science ®Google Scholar
• Cronin M , MorrisseyD, RajendranSet al. Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors. 18(7), 1397–1407 (2010).
   Google Scholar
• Kitagawa K , OdaT, SaitoHet al. Development of oral cancer vaccine using recombinant Bifidobacterium displaying Wilms’ tumor 1 protein. 66(6), 787–798 (2017).
   Google Scholar
• Yin Y , WangRR, WangY, WangJJ, XuGX. Preparation of selenium-enriched Bifidobacterium longum and its effect on tumor growth and immune function of tumor-bearing mice. Asian Pac. J. Cancer Prev.15, 3681–3686 (2014).
   PubMedGoogle Scholar
• Li C , ChenX, KouLet al. Selenium–Bifidobacterium longum as a delivery system of endostatin for inhibition of pathogenic bacteria and selective regression of solid tumor. Exp. Ther. Med.1(1), 129–135 (2010).
   PubMed Web of Science ®Google Scholar
• Li X , FuGF, FanYRet al. Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth. Cancer Gene Ther.10(2), 105–111 (2003).
   PubMed Web of Science ®Google Scholar
• Fu G-F , LiX, HouY-Y, FanY-R, LiuW-H, XuG-X. Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer. Cancer Gene Ther.12(2), 133 (2005).
   PubMed Web of Science ®Google Scholar
• Chen B , ZhangY, XiaoS, GuP, LinX. Personalized image-based templates for iliosacral screw insertions: a pilot study. Int. J. Med. Robot.8(4), 476–482 (2012).
   PubMed Web of Science ®Google Scholar
• Zhu H , LiZ, MaoSet al. Antitumor effect of sFlt-1 gene therapy system mediated by Bifidobacterium infantis on Lewis lung cancer in mice. Cancer Gene Ther.18(12), 884–896 (2011).
   PubMed Web of Science ®Google Scholar
• Guo B , XieN, WangY. Cooperative effect of Bifidobacteria lipoteichoic acid combined with 5-fluorouracil on hepatoma-22 cells growth and apoptosis. Bull. Cancer102(3), 204–212 (2015).
   PubMed Web of Science ®Google Scholar
• Hu B , KouL, LiCet al. Bifidobacterium longum as a delivery system of TRAIL and endostatin cooperates with chemotherapeutic drugs to inhibit hypoxic tumor growth. 16(8), 655 (2009).
   Google Scholar
• Tang W , HeY, ZhouS, MaY, LiuG. A novel Bifidobacterium infantis-mediated TK/GCV suicide gene therapy system exhibits antitumor activity in a rat model of bladder cancer. J. Exp. Clin. Cancer Res.28, 155 (2009).
   PubMed Web of Science ®Google Scholar
• Wang C , MaY, HuQet al. Bifidobacterial recombinant thymidine kinase–ganciclovir gene therapy system induces FasL and TNFR2 mediated antitumor apoptosis in solid tumors. 16(1), 545 (2016).
   Google Scholar
• Wang L , VuleticI, DengDet al. Bifidobacteriumbreve as a delivery vector of IL-24 gene therapy for head and neck squamous cell carcinoma in vivo. 24(11), 699 (2017).
   Google Scholar
• Xiao X , JinR, LiJ, BeiY, WeiT. The antitumor effect of suicide gene therapy using Bifidobacterium infantis-mediated herpes simplex virus thymidine kinase/ganciclovir in a nude mice model of renal cell carcinoma. Urology84(4), 982, e915–e920 (2014).
   Web of Science ®Google Scholar
• Yin X , YuB, TangZet al. Bifidobacterium infantis-mediated HSV-TK/GCV suicide gene therapy induces both extrinsic and intrinsic apoptosis in a rat model of bladder cancer. Cancer Gene Ther.20(2), 77–81 (2013).
   PubMed Web of Science ®Google Scholar
• Zhou H , HeZ, WangCet al. Intravenous administration is an effective and safe route for cancer gene therapy using the bifidobacterium-mediated recombinant HSV-1 thymidine kinase and ganciclovir. Int. J. Mol. Sci.17(6), (2016).
   Web of Science ®Google Scholar
• Yamamoto S , SuzukiS, HoshinoA, AkimotoM, ShimadaT. Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in mice. Cancer Gene Ther.4(2), 91–96 (1997).
   PubMed Web of Science ®Google Scholar
• Johnstone RW , FrewAJ, SmythMJ. The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nat. Rev. Cancer8(10), 782–798 (2008).
   PubMed Web of Science ®Google Scholar
• Hou X , LiuJE. Construction of Escherichia coli-Bifidobacterium longum shuttle vector and expression of tumor suppressor gene PTEN in B. longum. Wei Sheng Wu Xue Bao46(3), 347–352 (2006).
   PubMedGoogle Scholar
• Hollander MC , BlumenthalGM, DennisPA. PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat. Rev. Cancer11(4), 289–301 (2011).
   PubMed Web of Science ®Google Scholar
• Kikuchi T , ShimizuH, AkiyamaY, TaniguchiS. In situ delivery and production system of trastuzumab scFv with Bifidobacterium. Biochem. Biophys. Res. Commun.493(1), 306–312 (2017).
   PubMed Web of Science ®Google Scholar
• Zhuo Z , HuJ, YangXet al. Ailanthone inhibits Huh7 cancer cell growth via cell cycle arrest and apoptosis in vitro and in vivo. Sci. Rep.5, 16185 (2015).
   PubMed Web of Science ®Google Scholar
• Hidaka A , HamajiY, SasakiT, TaniguchiS, FujimoriM. Exogenous cytosine deaminase gene expression in Bifidobacterium breve I-53-8w for tumor-targeting enzyme/prodrug therapy. Biosci. Biotechnol. Biochem.71(12), 2921–2926 (2007).
   PubMed Web of Science ®Google Scholar
• Nakamura T , SasakiT, FujimoriMet al. Cloned cytosine deaminase gene expression of Bifidobacterium longum and application to enzyme/pro-drug therapy of hypoxic solid tumors. Biosci. Biotechnol. Biochem.66(11), 2362–2366 (2002).
   PubMed Web of Science ®Google Scholar
• An LN , LiZH, YueY, WangSR, GuoZY. Gene therapy for melanoma by Bifidobacterium infantis-mediated transfer of CD and UPRT genes with 5-FC in vitro. Sichuan Da Xue Xue Bao Yi Xue Ban38(1), 27–30 (2007).
   PubMedGoogle Scholar
• Taniguchi S , ShimataniY, FujimoriM. Tumor-targeting therapy using gene-engineered anaerobic-nonpathogenic Bifidobacterium longum. Methods Mol. Biol.1409, 49–60 (2016).
   PubMedGoogle Scholar
• Fox ME , LemmonMJ, MauchlineMLet al. Anaerobic bacteria as a delivery system for cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered clostridia. Gene Ther.3(2), 173–178 (1996).
   PubMed Web of Science ®Google Scholar
• Liu SC , MintonNP, GiacciaAJ, BrownJM. Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis. Gene Ther.9(4), 291–296 (2002).
   PubMed Web of Science ®Google Scholar
• Minton NP , MauchlineML, LemmonMJet al. Chemotherapeutic tumour targeting using clostridial spores. FEMS Microbiol. Rev.17(3), 357–364 (1995).
   PubMed Web of Science ®Google Scholar
• Boddy A , AaronsL, PetrakK. Efficiency of drug targeting: steady-state considerations using a three-compartment model. Pharm. Res.6(5), 367–372 (1989).
   PubMed Web of Science ®Google Scholar
• Petrak KJ . Precision medicine and site-specific drug delivery. Arch. Cancer Res.3, 1–4 (2015).
   Google Scholar